InvestorsHub Logo
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

Re: surf1944 post# 2253

Saturday, 09/11/2010 7:19:21 AM

Saturday, September 11, 2010 7:19:21 AM

Post# of 3562
The reasons given to the upgrade were: generic Effexor XR, the denial of motion for summary judgment filed by Sandoz/Momenta in the Copaxone patent litigation, and possible near term competition by Gilenia not that bad.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TEVA News